Albion Human Nutrition announced today that their proprietary patented product, Creatine MagnaPower® received GRAS Status, having been reviewed and approved by a third‐party expert panel. This proprietary product contains creatine chelated with magnesium, both well-known muscle nutrients. This combination facilitates vital ATP production and oxygen delivery to working muscles, and it is backed by scientific research and clinical trials.
Creatine is one of the most popular sports supplements in the world. Surveys performed on creatine use in athletes indicate that creatine is used by over 40 percent of athletes in the National Collegiate Athletic Association (NCAA). Research shows that the regular use of creatine supplements in aging adults can greatly reduce muscle loss due to sarcopenia as we age.
According to Albion, the company has discovered and patented a way to create a single molecule by combining creatine with a single magnesium atom. This special molecule form, called a chelate, is Creatine MagnaPower and has scientifically proven advantages—giving consumers a performance edge when they need it most. The successful acquisition of a CAS number for this product and others manufactured by Albion can aid in further registration in individual countries, thus supporting an expanding sales effort and world‐wide demand of their products. To learn more about Creatine MagnaPower, visit its consumer website dedicated to this proprietary product: creatinemagnapower.com.